These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37253814)

  • 1. Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities.
    Sharma A; Choi JSY; Watson AMD; Li L; Sonntag T; Lee MKS; Murphy AJ; De Blasio M; Head GA; Ritchie RH; de Haan JB
    Sci Rep; 2023 May; 13(1):8741. PubMed ID: 37253814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
    Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
    Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
    Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis.
    Rajesh M; Mukhopadhyay P; Bátkai S; Arif M; Varga ZV; Mátyás C; Paloczi J; Lehocki A; Haskó G; Pacher P
    Geroscience; 2022 Jun; 44(3):1727-1741. PubMed ID: 35460032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.
    Rosa CM; Gimenes R; Campos DH; Guirado GN; Gimenes C; Fernandes AA; Cicogna AC; Queiroz RM; Falcão-Pires I; Miranda-Silva D; Rodrigues P; Laurindo FR; Fernandes DC; Correa CR; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2016 Sep; 15(1):126. PubMed ID: 27585437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
    Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
    Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.
    Liang D; Zhong P; Hu J; Lin F; Qian Y; Xu Z; Wang J; Zeng C; Li X; Liang G
    J Mol Cell Cardiol; 2015 May; 82():63-74. PubMed ID: 25758431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
    Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
    Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats.
    Rosa CM; Xavier NP; Henrique Campos D; Fernandes AA; Cezar MD; Martinez PF; Cicogna AC; Gimenes C; Gimenes R; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2013 Oct; 12():152. PubMed ID: 24134628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
    Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
    Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cardiac inflammation and remodeling during the development of streptozotocin-induced diabetic cardiomyopathy in vivo: a time course analysis.
    Becher PM; Lindner D; Fröhlich M; Savvatis K; Westermann D; Tschöpe C
    Int J Mol Med; 2013 Jul; 32(1):158-64. PubMed ID: 23652584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
    Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
    Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes.
    De Blasio MJ; Huynh N; Deo M; Dubrana LE; Walsh J; Willis A; Prakoso D; Kiriazis H; Donner DG; Chatham JC; Ritchie RH
    Front Physiol; 2020; 11():124. PubMed ID: 32153425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Diabetes Induction on the Rat Heart: Differences in Oxidative Stress, Inflammatory Cells, and Fibrosis between Subendocardial and Interstitial Myocardial Areas.
    Guido MC; Marques AF; Tavares ER; Tavares de Melo MD; Salemi VMC; Maranhão RC
    Oxid Med Cell Longev; 2017; 2017():5343972. PubMed ID: 28781721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT6‑specific inhibitor OSS‑128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress.
    Huang Y; Zhang J; Xu D; Peng Y; Jin Y; Zhang L
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
    Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
    Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension is a conditional factor for the development of cardiac hypertrophy in type 2 diabetic mice.
    van Bilsen M; Daniels A; Brouwers O; Janssen BJ; Derks WJ; Brouns AE; Munts C; Schalkwijk CG; van der Vusse GJ; van Nieuwenhoven FA
    PLoS One; 2014; 9(1):e85078. PubMed ID: 24416343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
    Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
    Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.